Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
Clinical trial NCT05779241 · COMPLETED
Trial details
- NCT number
- NCT05779241
- Sponsor
- Lyndra Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2023-11-03
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.